Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report)’s share price hit a new 52-week low during trading on Thursday . The stock traded as low as $0.0001 and last traded at $13.93, with a volume of 402 shares changing hands. The stock had previously closed at $0.0001.
Better Therapeutics Stock Performance
The company has a market capitalization of $4,058.00, a P/E ratio of 0.00 and a beta of 0.97.
About Better Therapeutics
Better Therapeutics, Inc is a clinical-stage digital therapeutics company focused on developing prescription software-based treatments for cardiometabolic diseases. Its lead product candidate, BT-001, is a behavior-change program delivered via a smartphone application, designed to address underlying drivers of type 2 diabetes and hypertension through cognitive behavioral therapy techniques. The company’s platform is built to engage patients in personalized lifestyle modification, leveraging real-time feedback and data analytics to support sustained clinical improvements.
BT-001 is being evaluated in pivotal clinical trials under FDA investigational device exemptions, with studies examining its impact on glycemic control and blood pressure reduction.
Further Reading
- Five stocks we like better than Better Therapeutics
- Is Elon Preparing for a Silver Shock?
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- How AI-enabled Sensors are Solving the Technology Gap Inside America’s Airports
- Trump’s AI Secret: 100X Faster Than Nvidia
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Better Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Better Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
